Preface on Esophagus Cancer1
Preface on Esophagus Cancer
Chinese Clinical Oncology
2017;
6
(5)
:44
.
(31 October 2017)
Review Article on Esophagus Cancer1
Radiation techniques for esophageal cancer
Chinese Clinical Oncology
2017;
6
(5)
:45
.
(31 October 2017)
The management of localized esophageal squamous cell carcinoma: Western approach
Chinese Clinical Oncology
2017;
6
(5)
:46
.
(31 October 2017)
Surgical management of esophageal cancer
Chinese Clinical Oncology
2017;
6
(5)
:47
.
(31 October 2017)
Systemic therapy for esophagogastric cancer: targeted therapies
Chinese Clinical Oncology
2017;
6
(5)
:48
.
(31 October 2017)
Systemic therapy for esophageal cancer: chemotherapy
Chinese Clinical Oncology
2017;
6
(5)
:49
.
(31 October 2017)
Screening and prevention strategies and endoscopic management of early esophageal cancer
Chinese Clinical Oncology
2017;
6
(5)
:50
.
(31 October 2017)
Issues in the management of esophageal cancer and geriatric patients
Chinese Clinical Oncology
2017;
6
(5)
:51
.
(31 October 2017)
Adenocarcinoma of the esophagus: controversies and consensus
Chinese Clinical Oncology
2017;
6
(5)
:52
.
(31 October 2017)
Systemic therapy for esophagogastric cancer: immune checkpoint inhibition
Chinese Clinical Oncology
2017;
6
(5)
:53
.
(31 October 2017)
Review Article
Rational combination of immunotherapy for triple negative breast cancer treatment
Chinese Clinical Oncology
2017;
6
(5)
:54
.
(31 October 2017)
Editorial
Trastuzumab biosimilar in early breast cancer setting: will there be direct patient benefits?
Chinese Clinical Oncology
2017;
6
(5)
:55
.
(31 October 2017)
Meet the Professor2
ERAS & Tubeless—Michael Haddock: the past and future of proton beam
Chinese Clinical Oncology
2017;
6
(5)
:56
.
(31 October 2017)
Disclosure:
1. The series “Esophagus Cancer” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Geoffrey Y. Ku and David H. Ilson served as the unpaid Guest Editors for the series.
2. The series “Meet the Professor” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding.
